scholarly article | Q13442814 |
P356 | DOI | 10.18632/ONCOTARGET.4450 |
P8608 | Fatcat ID | release_ph5rqthdfnazpiruja5h6hzap4 |
P932 | PMC publication ID | 4695154 |
P698 | PubMed publication ID | 26172297 |
P5875 | ResearchGate publication ID | 279679456 |
P50 | author | Changhua Zhuo | Q57628179 |
P2093 | author name string | Dawei Li | |
Bin Li | |||
Yiwei Li | |||
Qingguo Li | |||
Yuchen Wu | |||
Sanjun Cai | |||
Xinxiang Li | |||
Guoxiang Cai | |||
Junjie Peng | |||
Peng Lian | |||
Jia Nie | |||
P2860 | cites work | Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project | Q21061203 |
Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes | Q24550997 | ||
CpG Island Methylation in Colorectal Cancer: Past, Present and Future | Q24597977 | ||
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field | Q24620628 | ||
Microsatellite instability in colorectal cancer | Q24627393 | ||
Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 | ||
CpG island methylator phenotype in colorectal cancer | Q24672170 | ||
Analysis of repetitive element DNA methylation by MethyLight | Q24814952 | ||
Cancer statistics, 2015 | Q27860576 | ||
A genetic model for colorectal tumorigenesis | Q27860582 | ||
Mutations of the BRAF gene in human cancer | Q27860760 | ||
High frequency of mutations of the PIK3CA gene in human cancers | Q28131776 | ||
Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum | Q28262150 | ||
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer | Q28289377 | ||
The epigenomics of cancer | Q28289975 | ||
Systematic review of microsatellite instability and colorectal cancer prognosis | Q28303189 | ||
Mobile elements: drivers of genome evolution | Q29547669 | ||
Epigenetics in cancer | Q29547853 | ||
Epigenetics in cancer | Q29617139 | ||
Hypomethylation distinguishes genes of some human cancers from their normal counterparts | Q29619217 | ||
LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability | Q33283510 | ||
Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample | Q33383866 | ||
DNA demethylation in normal colon tissue predicts predisposition to multiple cancers | Q33581249 | ||
Colorectal advanced neoplasms occur through dual carcinogenesis pathways in individuals with coexisting serrated polyps | Q33645406 | ||
A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers | Q33808550 | ||
Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency | Q33811768 | ||
Body size, physical activity and risk of colorectal cancer with or without the CpG island methylator phenotype (CIMP). | Q33869180 | ||
Four Molecular Subtypes of Colorectal Cancer and Their Precursor Lesions | Q33918795 | ||
DNA repair defects inactivate tumor suppressor genes and induce hereditary and sporadic colon cancers. | Q33923968 | ||
NRAS mutations are rare in colorectal cancer | Q34091172 | ||
Transcribed dark matter: meaning or myth? | Q34192913 | ||
Mobile elements and mammalian genome evolution. | Q34279041 | ||
Cancer Genetics and Epigenetics: Two Sides of the Same Coin? | Q34287662 | ||
The CpG island methylator phenotype: what's in a name? | Q34353612 | ||
Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer | Q34358286 | ||
MGMT promoter methylation and field defect in sporadic colorectal cancer. | Q34452509 | ||
Mechanisms underlying losses of heterozygosity in human colorectal cancers | Q34485665 | ||
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). | Q34557362 | ||
The chromosomal instability pathway in colon cancer | Q34570062 | ||
Defining 'chromosomal instability'. | Q34735361 | ||
DNA methylation in cancer: too much, but also too little | Q34770545 | ||
Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype | Q34975498 | ||
Mutational analysis and clinical correlation of metastatic colorectal cancer | Q35082873 | ||
Methylation of MGMT and ADAMTS14 in normal colon mucosa: biomarkers of a field defect for cancerization preferentially targeting elder African-Americans | Q35550260 | ||
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands | Q35595265 | ||
The 5-methylcytosine content of DNA from human tumors | Q35689206 | ||
Somatic DNA Hypomethylation in H. pylori-Associated High-Risk Gastritis and Gastric Cancer: Enhanced Somatic Hypomethylation Associates with Advanced Stage Cancer | Q35694210 | ||
Genome-scale analysis of aberrant DNA methylation in colorectal cancer | Q35694387 | ||
The relationship between hypomethylation and CpG island methylation in colorectal neoplasia | Q35749254 | ||
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis | Q35790157 | ||
Epigenetic Differences in Normal Colon Mucosa of Cancer Patients Suggest Altered Dietary Metabolic Pathways | Q35803768 | ||
Lymph node count after preoperative radiotherapy is an independently prognostic factor for pathologically lymph node-negative patients with rectal cancer | Q36151978 | ||
Molecular classification and correlates in colorectal cancer | Q36329300 | ||
Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry | Q36401944 | ||
DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer | Q36613849 | ||
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features | Q36699559 | ||
Epigenetic field for cancerization | Q36774336 | ||
The genetics of hereditary colon cancer | Q36972251 | ||
LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. | Q37070832 | ||
A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer | Q37090752 | ||
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers | Q37091263 | ||
Role of the serrated pathway in colorectal cancer pathogenesis | Q37737403 | ||
Raf inhibitors target ras spatiotemporal dynamics | Q39353461 | ||
President's address. The polyp-cancer sequence in the large bowel | Q39429566 | ||
Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. | Q40550191 | ||
A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements | Q40587967 | ||
BRAF: a driver of the serrated pathway in colon cancer | Q44139607 | ||
Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. | Q44274945 | ||
The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer | Q46073818 | ||
Epigenetic patterns in the progression of esophageal adenocarcinoma | Q46291635 | ||
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer | Q46578998 | ||
Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage | Q46846179 | ||
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. | Q51597972 | ||
Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features. | Q54583151 | ||
Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer. | Q54631097 | ||
Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation | Q61865611 | ||
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers | Q71167724 | ||
DNA hypomethylation in Morris hepatomas | Q72708568 | ||
Human genome: end of the beginning | Q80890009 | ||
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization | Q80980462 | ||
Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component | Q81105482 | ||
Molecular Genetics of Colorectal Cancer | Q82521439 | ||
DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia | Q83364381 | ||
Metastatic lymph node ratio can further stratify prognosis in rectal cancer patients treated with preoperative radiotherapy: a population-based analysis | Q87518636 | ||
P433 | issue | 27 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 23820-23836 | |
P577 | publication date | 2015-09-01 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer | |
P478 | volume | 6 |
Q61445790 | Association between serum 25-hydroxyvitamin D and global DNA methylation in visceral adipose tissue from colorectal cancer patients |
Q89171911 | Meta-analysis of the prognostic value of CpG island methylator phenotype in rectal cancer |
Q42378523 | Negative lymph node count is a significant prognostic factor in patient with stage IV gastric cancer after palliative gastrectomy |
Q99240820 | Promoter methylation, transcription, and retrotransposition of LINE-1 in colorectal adenomas and adenocarcinomas |
Q40273466 | The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis |
Q37109630 | Tumor size is an independent risk predictor for metachronous colorectal cancer |
Search more.